Investing Center Preview – Manage your investments and watch your net worth grow.
EYPT:NASDAQ – Small Cap Stock (Biotechnology)
EyePoint Pharmaceuticals Inc – EYPT Stock Overview
Last Price | Today's Change | 52-Week Range | Trading Volume |
---|---|---|---|
4.99 | -0.38 (-7.08%) | 4.83 - 23.65 | 928.9 thousand (Above Avg) |
Market data as of 3:59PM 04/03/25. Quotes are delayed by at least 15 min.
Overview - EYPT
Open | 5.02 |
---|---|
Previous Close | 5.37 |
Day's Range | 4.83 - 5.13 |
Market Cap | 343.0M |
Avg Volume (10 Day) | 814.6K |
Price/Earnings (Trailing 12 Mo.) | -- |
Earnings Per Share (Trailing 12 Mo.) | -0.891 |
Dividend Yield | No Dividend |
One-Click Scorecard - EYPT


These seven metrics are a snap to calculate, thanks to Quicken.com's One-Click Scorecard. Our goal with this tool is to help you evaluate potential investment candidates and eliminate those equities that aren't up to snuff. One-Click Scorecard won't do all the homework necessary for you to reach a decision, but it will help you develop a list of quality stocks to watch and study further.
Performed well consistently? | Fail |
---|---|
Avoids excess debt? | Fail |
Converting sales to profits? | Fail |
Shareholder's money handled rationally? | Neutral |
Increased shareholder value? | Neutral |
Consistently increased owner earnings? | Fail |
Sells at 25% discount to intrinsic value? | Fail |


These eight metrics are a snap to calculate, thanks to Quicken.com's One-Click Scorecard. Our goal with this tool is to help you evaluate potential investment candidates and eliminate those equities that aren't up to snuff. One-Click Scorecard won't do all the homework necessary for you to reach a decision, but it will help you develop a list of quality stocks to watch and study further.
Pays a cash dividend? | Neutral |
---|---|
Room to increase dividends? | Fail |
Increased earnings over time? | Neutral |
Borrows within reasonable limits? | Pass |
Stock is undervalued? | Fail |
Have investors caught on? | Fail |
Has support of institutional investors? | Fail |
Has sufficient liquidity? | Pass |
Latest Headlines - EYPT
No news headlines available for EYPT
Industry Position - EYPT
EYPT | Industry Range | |
---|---|---|
Revenue Growth (1yr) | -5.96% | |
Net Income Growth (1yr) | -- | |
Total Debt/Equity | 0.06 | |
LT Debt/Equity | 0.06 | |
Earnings Yield | -- | |
Price/Sales | 6.57 |
Competitors - EYPT
Company | Last | Change |
---|---|---|
Aldeyra Therapeutics Inc | 1.42 | -73.33% |
15.87 | -6.65% | |
15.00 | -1.96% | |
26.00 | 0.00% | |
Taysha Gene Therapies Inc | 1.26 | -4.55% |
Data is delayed by at least 15 min.